Patient Care Outreach, Navigation, Technology and Support 2.0
About this study
This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.
- Condition
- Breast Cancer, Cardiovascular Diseases
- Tested
- Patient Navigation Program, Quality-of-Life (QOL) Assessment, Survey Administration
- Sponsor
- University of California, San Francisco
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 12
- Minimum age: 18 years
- Study condition: Breast Cancer, Cardiovascular Diseases
- For Focus groups:
- Breast cancer patients: Diagnosed with breast cancer, ages 18 or older, speaks English, Mandarin/Cantonese, or Spanish
- Navigators: any patient navigator who has provided care to underserved populations diagnosed with cancer
- For Portal Implementation phase:
- Ages 18 or older
- Speaks English, Mandarin/Cantonese, Spanish,
- Has any stage breast cancer
- Has access to a phone that is able to receive text messages, is willing to stay in the study for six-seven months.
- Family User experience survey:
- Family member or friend who may have assisted breast cancer participant with registration, accessing or otherwise assisting breast cancer family member or friend participant with the online portal.
Exclusion 1
- Any medical or psychological conditions precluding informed consent
Where
2 sites, 2 recruiting
Zuckerberg San Francisco General Hospital
San Francisco, California, United States
University of California, San Francisco
San Francisco, California, United States
Contact
-
Laura Allen
415-818-7143 Laura.Allen@ucsf.edu
Potential match only. Final eligibility is determined by the study team.